Article: Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders

€3.03

SKU: product-article-21008 Category: General

Description
Reviews (0)

Description

Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders

Reviews

There are no reviews yet.

Be the first to review “Article: Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders”

You must be logged in to post a review.

Top

Article: Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders

Description

Reviews

Related products

Article: Highlights in breast cancer

Article: Highlights in gynaecological cancers

1 year access Online Belgian Journal of Hematology (BJH)

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma